NanoCell

Intrauterine Treatment for Improving Embryo Implantation Rates

Active Pre-Seed Startup Rehovot Founded 2015-01

NanoCell is dedicated to advancing womens reproductive health through biopharmaceutical technologies. The companys proprietary intrauterine treatment significantly improves embryo implantation, thereby increasing the chances of conception. NanoCell is developing a method, kit, and composition for increasing the implantation rate of embryos in both humans an…

SectorHealth Tech & Life Sciences
StagePre-Seed
Employees6
Founded2015-01
HQRehovot
Patents1
Confidence83
Sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Materials & SubstancesImplantsComposites
Target customers
Healthcare & Life SciencesHealthcareProvidersConsumersDemographics & FamilyWomen